ArticleFrontiers in oncology2020

TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.

Jie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.